SCHEMBL4778824

SCHEMBL4778824

COC(=O)CN(CCc1ccc(O[Si](C)(C)C(C)(C)C)cc1)C(=O)Oc1cccc(OC)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 2/20 0.42
LPAR5 Q9H1C0 2/20 0.42
ADRB3 P13945 1/20 0.41
PPARD Q03181 3/20 0.39
PPARA Q07869 3/20 0.39
PPARG P37231 2/20 0.39
ACHE P22303 1/20 0.38
VDR P11473 2/20 0.37
ALDH1A1 P00352 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
TSHR P16473 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 2/20 0.36
ALOX5 P09917 1/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4781591 0.86 ADRB3 (0.39) ADRB3PPARDPPARAPPARGMAPT
SCHEMBL4780684 0.83 LPAR1 (0.45) LPAR1LPAR5ACHEALDH1A1TDP1
SCHEMBL4905528 0.80 PPARG (0.43) PPARAPPARGACHEALDH1A1TSHR
SCHEMBL4778818 0.80 PPARG (0.43) PPARAPPARGACHEALDH1A1TSHR
SCHEMBL7535671 0.72 F2RL1 (0.46) PPARDPPARGVDRALDH1A1MAPT
SCHEMBL13899312 0.69 PPARG (0.38) PPARAPPARGALDH1A1TSHRKMT2A
SCHEMBL4779393 0.69 ESR1 (0.39) PPARAPPARGMAPTKDM4EESR1
SCHEMBL3839217 0.69 CYP4F2 (0.50) ALDH1A1MAPTKMT2AKDM4EMEN1
SCHEMBL5292779 0.69 ACHE (0.45) ACHEALDH1A1CYP3A4
SCHEMBL4775931 0.68 ALDH1A1 (0.41) ADRB3ALDH1A1TDP1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008006044-A2 SUBSTITUTED ACID DERIVATIVES USEFUL AS ANTIDIABETIC AND ANTIOBESITY AGENTS AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 2008-01-10 WO disclosed